Did you buy KD securities between August 7, 2024, and February 9, 2026? Affected Kyndryl Holdings, Inc. Investor Summary Who: Kyndryl Holdings, Inc. (NYSE: KD)What: Securities fraud class action lawsuit filedClass Period: August 7, 2024, through February 9, 2026Deadline to Seek Lead Plaintiff Status: April 13, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s cash management practices and internal control over financial reporting.Investor Action: Contact Kessler T ...

Core Insights - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of investors of Commvault Systems, Inc. [1] - Commvault reported a 40% growth in SaaS ARR to $364 million for Q3 fiscal 2026, but this represents a deceleration from the 56% growth reported in Q2 fiscal 2026 [2] - Following the earnings report, Commvault's stock price dropped by approximately 31.1%, from $129.36 to $89.13 per share [3] Company Performance - Commvault's SaaS ARR reached $364 million, indicating significant growth [2] - The company experienced a notable deceleration in growth rate, dropping from 56% to 40% [2] Market Reaction - The stock price decline of $40.23 per share reflects investor concerns regarding the deceleration in growth [3]

Core Viewpoint - Klarna Group plc is facing a securities fraud class action lawsuit due to significant losses incurred by investors following its IPO and subsequent financial disclosures that revealed a substantial increase in credit loss provisions [1] Group 1: Company Overview - Klarna Group plc conducted its IPO on September 10, 2025, selling 34.3 million shares at $40 per share [1] - Following the IPO, the company's stock price has significantly declined, closing at $31.63 per share on November 18, 2025, after a 9.3% drop due to negative financial results [1] Group 2: Financial Performance - In its third quarter 2025 financial results, Klarna reported a 39% increase in its provision for credit losses, attributed to changes in market and product mix, particularly an increased share of the U.S. market in its Gross Merchandise Volume (GMV) [1] Group 3: Legal Proceedings - The class action lawsuit alleges that Klarna's management made materially false and misleading statements regarding the company's business and operations, particularly underestimating the risk of increased loss reserves shortly after the IPO [1] - Investors who acquired Klarna securities in connection with the IPO have until February 20, 2026, to seek appointment as lead plaintiffs in the lawsuit [1]

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain officers for alleged violations of federal securities laws during the Class Period from January 17, 2025, to November 13, 2025, seeking damages for affected investors [1]. Company Overview - Plug Power provides hydrogen fuel cell turnkey solutions for electric mobility and stationary power markets in North America and Europe, including hydrogen storage and production equipment [4]. - The company is committed to building a network of hydrogen production plants across the United States [4]. Financial Developments - In early 2021, Plug Power began applying for a loan through the U.S. Department of Energy's Loan Program, and on January 16, 2025, it announced a $1.66 billion loan guarantee from the DOE to finance the construction of up to six hydrogen production projects [5][6]. - The DOE Loan was contingent on meeting specific conditions, including technical and performance-related requirements [6]. Allegations and Misstatements - The lawsuit alleges that during the Class Period, Plug Power's executives made materially false and misleading statements regarding the availability of funds from the DOE Loan and the company's ability to construct necessary facilities [7]. - It is claimed that the company overstated the likelihood of receiving DOE funds and that it was likely to pivot towards less ambitious projects [7]. Executive Changes - On October 7, 2025, Plug Power announced the resignation of CEO Andrew Marsh and President Sanjay Shrestha, with Chief Revenue Officer Jose Luis Crespo appointed to both roles, raising concerns about the company's stability [8]. - Following this announcement, Plug Power's stock price fell by 6.29% to close at $3.87 per share [9]. Recent Financial Results - On November 10, 2025, Plug Power reported financial results indicating a significant pivot in strategy, announcing the suspension of activities under the DOE loan program and the expectation of generating over $275 million in liquidity [10]. - This announcement led to a 3.39% decline in stock price to $2.53 per share [11]. Suspension of Projects - On November 13, 2025, it was reported that Plug Power confirmed the suspension of plans to construct six hydrogen production facilities, jeopardizing the $1.66 billion DOE Loan [11]. - Following this news, the stock price dropped by 17.58% over two trading sessions, closing at $2.25 per share [12].

Core Viewpoint - A class action lawsuit has been filed against Quantum Biopharma Ltd. for alleged securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of shareholders of Quantum Biopharma Ltd. and is being handled by Pomerantz LLP [1]. - Investors have until February 23, 2026, to request to be appointed as Lead Plaintiff if they purchased Quantum securities during the Class Period [2]. Group 2: Allegations Against Defendants - The complaint alleges that several financial institutions, including CIBC World Markets and RBC Capital Markets, engaged in manipulative trading practices by placing thousands of spoofed sell orders [4]. - These spoofed orders created a false impression of Quantum's stock price declining, leading other investors to sell their shares at artificially low prices [4]. - After driving the stock price down, the defendants purchased shares at these depressed levels to profit from the manipulation [4]. Group 3: Pomerantz LLP Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud [5]. - The firm has a track record of recovering multimillion-dollar damages for class members over its 85-year history [5].

Core Viewpoint - A class action lawsuit has been filed against Richtech Robotics Inc. for allegedly misleading investors about its relationship with Microsoft, leading to significant stock price declines when the truth was revealed [1][3]. Company Overview - Richtech Robotics Inc. is based in Las Vegas, Nevada, and specializes in designing and manufacturing AI-driven service robots for various industries, including hospitality, healthcare, and manufacturing [2]. Lawsuit Details - The lawsuit claims that Richtech misrepresented its relationship with Microsoft as a "hands-on collaboration" and "joint engineering effort," while it was actually a standard customer relationship [3]. - The market reacted negatively on January 27, 2026, when the truth about the relationship was disclosed, resulting in a substantial decline in Richtech's share price [3]. Investor Information - Investors who purchased Richtech securities during the class period from January 27, 2026, to January 29, 2026, have until April 3, 2026, to seek appointment as lead plaintiff representatives [2].

Core Viewpoint - ICON plc is under investigation for potential securities law violations following a significant drop in its stock price due to concerns over accounting practices and internal controls [2]. Group 1: Company Overview - ICON plc's shares fell nearly 40% on February 12, 2026, after the company announced that its Audit Committee is investigating certain accounting practices, including revenue recognition from 2023 through 2025 [2]. - The company expects to report material weaknesses in internal control over financial reporting and has delayed the release of its Q4 and FY25 financial results, while also withdrawing its previously issued 2025 guidance [2]. Group 2: Legal Investigation - Block & Leviton is investigating whether ICON plc committed securities law violations and may file an action to recover losses for investors [4]. - Investors who have lost money on their ICON plc investment are encouraged to contact Block & Leviton for potential recovery options [5]. Group 3: Investor Eligibility - Any investor who purchased ICON plc common stock and has experienced a decline in their shares may be eligible to participate in the investigation, regardless of whether they have sold their investment [3].

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit due to allegations of misleading investors about its relationship with Microsoft, which has resulted in significant stock price declines [1] Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Diez v. Richtech Robotics Inc., No. 26-cv-00231 (D. Nev.) and involves investors who purchased Richtech Robotics securities between January 27, 2026, and January 29, 2026 [1] - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [1] - Following the publication of an article by Hunterbrook Media on January 29, 2026, which denied any partnership with Microsoft, Richtech Robotics Class B stock fell more than 29% over two trading days [1] Group 2: Lead Plaintiff Process - Investors who suffered substantial losses during the class period can seek appointment as lead plaintiff in the class action lawsuit [1] - The lead plaintiff is typically the investor with the greatest financial interest in the case and represents the interests of all class members [1] - The lead plaintiff has the authority to select a law firm to litigate the case, but participation as lead plaintiff is not required to share in any potential recovery [1] Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [1] - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, significantly more than any other law firm [1] - Robbins Geller is recognized for obtaining some of the largest securities class action recoveries in history, including a record $7.2 billion in the Enron case [1]

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings, Corp. regarding potential breaches of fiduciary duties by certain officers and directors of the company [1]. Group 1: Investigation Details - The investigation is focused on whether certain officers and directors of Integer Holdings, Corp. breached their fiduciary duties to the company [1]. - Shareholders who purchased shares prior to July 25, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2][4]. Group 2: Allegations of Misconduct - A federal securities fraud class action complaint alleges that Integer Holdings, Corp. made materially false and misleading statements about its business and operations [3]. - Specific allegations include: 1. Integer overstated its competitive position in the EP manufacturing market [3]. 2. The company experienced a deterioration in sales related to two of its EP devices, contrary to claims of strong customer demand [3]. 3. Integer mischaracterized its EP devices as long-term growth drivers for its C&V segment [3]. 4. Positive statements made by the defendants about the company's business lacked a reasonable basis [3].

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Unicycive Therapeutics, Inc. regarding potential breaches of fiduciary duties by certain officers and directors of the company [1]. Group 1: Investigation Details - The investigation focuses on whether certain officers and directors of Unicycive Therapeutics, Inc. breached their fiduciary duties to the company [1]. - Shareholders who purchased Unicycive shares prior to March 29, 2024, and still hold them can seek corporate reforms and the return of funds at no cost [2][4]. Group 2: Allegations - A federal securities fraud class action complaint alleges that Unicycive's officers made false statements regarding the company's readiness to meet FDA manufacturing compliance requirements, overstating their regulatory prospects [3]. - The complaint claims that the public statements made by the defendants were materially false and misleading at all relevant times [3].